-
Health todayObesity, diabetes and GLP-1 new
Semaglutide for weight management and use of other prescribed medicines in Denmark
In 189,392 Danish semaglutide initiators, antiasthmatic use fell below trend (RR 0.82) while anxiolytic use rose (RR 1.16).
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 new
One in seven Danish anorexia patients became steadily more ill after diagnosis
Among 9,534 Danish patients with anorexia nervosa, one in seven became steadily more ill, with more psychiatric and physical illness in the five years after diagnosis.
Preprint · not peer-reviewed -
Health todayMental health new
Infection followed hip fracture in 43% of older Danish patients with dementia
Among 100,335 Danish hip fracture patients aged 65 and over, infection within 30 days reached 43.0% in those with dementia, as compared to 18.4% in matched comparators with dementia.
Peer-reviewed -
Health todayHeart and stroke refines
STEMI patients judged at high risk of shock had double the ten-year mortality
Among 1,574 Danish STEMI patients treated by primary angioplasty, those a score marked as at high risk of shock in hospital had ten-year mortality of 41% against 20%.
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 refines
Unemployed and unmarried Danes start cardioprotective diabetes drugs less often
Among 81,361 Danes with type 2 diabetes and cardiovascular disease, unemployed men started cardioprotective glucose-lowering drugs at 0.77 times the rate of employed men, and unemployed women 0.81 times.
Peer-reviewed -
Health todayFrailty and multimorbidity refines
Combined conditions add mortality beyond their separate effects after emergency surgery
Among 61,400 Danish adults having major emergency abdominal surgery, 31% died within a year, and several combinations of chronic conditions were associated with mortality beyond their effects in isolation.
Peer-reviewed -
Health todayCancer contradicts
Reanalysed mammography trials are compatible with breast cancer overdiagnosis below 5%
A reanalysis of randomised mammography trials, benchmarked against Denmark's Funen screening programme, found the extra cancers detected compatible with breast cancer overdiagnosis below 5%, against published estimates up to 50%.
Peer-reviewed
